000 01138 a2200289 4500
005 20250516221019.0
264 0 _c20150528
008 201505s 0 0 eng d
022 _a1537-6591
024 7 _a10.1093/cid/ciu471
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVan de Verg, Lillian L
245 0 0 _aEditorial commentary: a Shigella vaccine against prevalent serotypes.
_h[electronic resource]
260 _bClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_cOct 2014
300 _a942-3 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aDrug Discovery
_xmethods
650 0 4 _aDysentery, Bacillary
_xepidemiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aShigella
_xclassification
650 0 4 _aShigella Vaccines
_ximmunology
700 1 _aVenkatesan, Malabi M
773 0 _tClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_gvol. 59
_gno. 7
_gp. 942-3
856 4 0 _uhttps://doi.org/10.1093/cid/ciu471
_zAvailable from publisher's website
999 _c23946420
_d23946420